2004
DOI: 10.1074/jbc.m308934200
|View full text |Cite
|
Sign up to set email alerts
|

The Cavity Structure for Docking the K+-competitive Inhibitors in the Gastric Proton Pump

Abstract: 2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile (SCH 28080) is a reversible inhibitor specific for the gastric proton pump. The inhibition pattern is competitive with K ؉ . Here we studied the binding sites of this inhibitor on the putative three-dimensional structure of the gastric proton pump ␣-subunit that was constructed by homology modeling based on the structure of sarcoplasmic reticulum Ca 2؉ pump. Alanine and serine mutants of Tyr 801 located in the fifth transmembrane segment of the ga… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(28 citation statements)
references
References 48 publications
1
27
0
Order By: Relevance
“…Mutations towards the exoplasmic surface of TM4, TM5 [3], TM6, the loop between TM5 and TM6, and one site at the end of TM8 altered either the K i or changed the nature of inhibition from strictly competitive to mixed or even non-competitive without affecting ion affinity. Mutation of lysine 791 to serine greatly reduced enzyme activity as well as increased the K i for SCH28080 [31,64,66].…”
Section: Acid Pump Antagonistsmentioning
confidence: 99%
“…Mutations towards the exoplasmic surface of TM4, TM5 [3], TM6, the loop between TM5 and TM6, and one site at the end of TM8 altered either the K i or changed the nature of inhibition from strictly competitive to mixed or even non-competitive without affecting ion affinity. Mutation of lysine 791 to serine greatly reduced enzyme activity as well as increased the K i for SCH28080 [31,64,66].…”
Section: Acid Pump Antagonistsmentioning
confidence: 99%
“…This would account for photoaffinity labeling of the M1M2 membrane pair by a p-azido derivative of SCH28080 (32). The interaction of Y799 with the inhibitor was investigated in recent site-specific mutagenesis studies identifying this residue as an important binding determinant (55). The binding site orientation of SCH28080 proposed by Asano et al (55), however, is rotated ~90°w ith respect to that shown in Figure 4C to make the imidazopyridine ring roughly coplanar with respect to the membrane plane.…”
Section: Inhibitor Binding To the New E 2 P Modelmentioning
confidence: 99%
“…The interaction of Y799 with the inhibitor was investigated in recent site-specific mutagenesis studies identifying this residue as an important binding determinant (55). The binding site orientation of SCH28080 proposed by Asano et al (55), however, is rotated ~90°w ith respect to that shown in Figure 4C to make the imidazopyridine ring roughly coplanar with respect to the membrane plane. More importantly, this proposed binding mode does not account for the complete elimination of binding in the A335C mutant.…”
Section: Inhibitor Binding To the New E 2 P Modelmentioning
confidence: 99%
“…For numbering the amino acid sequence of the gastric H ϩ ,K ϩ -ATPase ␣-subunit, the cDNA sequence of the rabbit gastric H ϩ ,K ϩ -ATPase ␣-subunit (GenBank TM accession number P27112) was adopted. Site-directed mutagenesis was performed using the QuikChange II site-directed mutagenesis kit as described previously (21). The mutated cDNA sequences were verified using a Long-Read Tower DNA sequencer (GE Healthcare).…”
Section: Methodsmentioning
confidence: 99%